Pfizer Inc.: Breakthroughs that Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.

Prevenar 13 is a Pneumococcal 13-valent Conjugate Vaccine (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F of the bacterium Streptococcus pneumoniae). Prevenar 13 is used to protect children aged between six weeks and 17 years against invasive disease, pneumonia and acute otitis media caused by S. pneumoniae. It is also used to protect adults 18 years of age and older against invasive disease and pneumonia caused by Streptococcus pneumoniae.

COMIRNATY® is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 5-11 years old, and 12 years of age and older.

PP-CMR -KOR-0122-20Dec2022

For product and safety information, click on each image and then click on Product Authorization Information button at the bottom of the page.